• Home
  • News
    ▼
    • Featured Paper of the Month
    • Reviews to Read
    • Hot off the Press
    • IRP News
    • Awards
    • Technology Development Initiative Paper of the Month
    • Seminar Schedule
  • About
    ▼
    • About NIDA IRP
    • Contact Us
    • Directions and Map
    • Careers at NIDA IRP
  • Organization
    ▼
    • Faculty
    • Office of the Scientific Director
    • Office of the Clinical Director
    • Office of Education and Career Development
    • Administrative Management Branch
    • Molecular Targets and Medications Discovery Branch
    • Cellular and Neurocomputational Systems Branch
    • Molecular Neuropsychiatry Research Branch
    • Neuroimaging Research Branch
    • Behavioral Neuroscience Research Branch
    • Integrative Neuroscience Research Branch
    • Translational Addiction Medicine Branch
    • Core Facilities
    • Women Scientist Advisors
  • Training Programs
    ▼
    • Office of Education and Career Development
    • OECD Awards
    • Summer Internship Program
    • Postbaccalaureate Program
    • Graduate Partnership Program
    • Postdoctoral Program
    • Diversity and Outreach Training Programs
    • NIDA Speakers Bureau
    • Clinical Electives Program
  • Study Volunteers
  • Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar

NIDA IRP

National Institute on Drug Abuse - Intramural Research Program

  National Institute on Drug Abuse | NIH IRP | Treatment Information
  • Home
  • News
    • Featured Paper of the Month
    • Reviews to Read
    • Hot off the Press
    • IRP News
    • Awards
    • Technology Development Initiative Paper of the Month
    • Seminar Schedule
  • About
    • About NIDA IRP
    • Contact Us
    • Directions and Map
    • Careers at NIDA IRP
  • Organization
    • Faculty
    • Office of the Scientific Director
    • Office of the Clinical Director
    • Office of Education and Career Development
    • Administrative Management Branch
    • Molecular Targets and Medications Discovery Branch
    • Cellular and Neurocomputational Systems Branch
    • Molecular Neuropsychiatry Research Branch
    • Neuroimaging Research Branch
    • Behavioral Neuroscience Research Branch
    • Integrative Neuroscience Research Branch
    • Translational Addiction Medicine Branch
    • Core Facilities
    • Women Scientist Advisors
  • Training Programs
    • Office of Education and Career Development
    • OECD Awards
    • Summer Internship Program
    • Postbaccalaureate Program
    • Graduate Partnership Program
    • Postdoctoral Program
    • Diversity and Outreach Training Programs
    • NIDA Speakers Bureau
    • Clinical Electives Program
  • Study Volunteers

Translational Addiction Medicine Branch

TAMB Logo and Lorenzo Leggio, M.D., Ph.D.Branch Chief

Lorenzo Leggio, M.D., Ph.D.

Contact

Location:
Biomedical Research Center
251 Bayview Boulevard
Suite 200, Room 04A515
Baltimore, MD 21224

Phone: 443-740-2801

Email: lorenzo.leggio@nih.gov

TAMB Mission

Founded by Dr. Lorenzo Leggio, the vision for the Translational Addiction Medicine Branch (TAMB) is to build a collaborative group of laboratories that span translational research via diverse approaches and methodologies, serving our collective goal to advance addiction science and medicine. With that in mind, the TAM team is uniquely positioned to achieve this mission, given the diversity of its Investigators/Labs, whose background, skillsets, expertise, and focus are quite distinct, yet complementary and synergistic. The mission of TAMB is to conduct translational clinical studies and execute cutting-edge human research that contributes to the understanding of addiction (e.g., deep, ecological momentary assessment and/or digital phenotyping) and the development of novel treatments (e.g., medications, behavioral interventions, technology-based modalities). Working under one roof, the TAMB team employs diverse approaches and levels of analysis across multiple platforms (wet-lab, animal program, outpatient and inpatient units, big data, and surveys) and study different species (mice, rats, non-human primates, and humans, the latter including both healthy volunteers and patient populations). Together, the TAMB is a patient-driven group of scientists and clinicians with diverse and synergistic backgrounds, ranging from medicine and experimental psychology to neuroscience and health communication.  The specific goals of the TAMB team are to:

  • Conduct addiction-related translational research – pre-clinical, animal benchwork to humans in clinical research settings, practice and across diverse patient populations
  • Develop novel effective addiction treatments and precision medicine approaches, including work on the intersection between addiction, health disparities and with patients with mental health and other medical comorbidities (e.g., liver disease, HIV, HCV, cardiovascular and metabolic disease)
  • Identify novel targets and develop new medications toward safe and effective therapies for patients with alcohol and substance use disorders
  • Develop innovative treatments that integrate evidenced-based research with novel methods and emerging technology targeting patients with alcohol and substance use disorders
  • Translate cutting edge research into novel treatments for addiction using predictive analytics, biosensors, mobile treatments, and personalized medicine

Branch Sections

  • Clinical Psychoneuroendocrinology and Neuropsychopharmacology Section
  • Technology and Translational Research Unit
  • Real-world Assessment, Prediction, and Treatment Unit
  • Computational Decision Neuroscience Unit (NIMH)

TAMB Vision and Research Portfolio - ACBD: adolescent brain cognitive development study; AUD: alcohol use disorder; EMA: ecological momentary assessment; fMRI: functional magnetic resonance imaging; OUD: opioid use disorder; PoC: proof-of-concept; RCTs: randomized controlled trials; SUD: substance use disorder

TAMB Vision and Research Portfolio.
ACBD: adolescent brain cognitive development study; AUD: alcohol use disorder; EMA: ecological momentary assessment; fMRI: functional magnetic resonance imaging; OUD: opioid use disorder; PoC: proof-of-concept; RCTs: randomized controlled trials; SUD: substance use disorder

Primary Sidebar

Translational Addiction Medicine Branch

  • TAMB Home
  • Staff
  • Clinical Psychoneuroendocrinology and Neuropsychopharmacology Section
  • Technology and Translational Research Unit
  • Real-world Assessment, Prediction, and Treatment Unit
  • Computational Decision Neuroscience Unit (NIMH)

Organization

  • Organization
  • Faculty
  • Office of the Scientific Director
  • Office of the Clinical Director
  • Administrative Management Branch
  • Molecular Targets and Medications Discovery Branch
  • Cellular and Neurocomputational Systems Branch
  • Molecular Neuropsychiatry Research Branch
  • Neuroimaging Research Branch
  • Behavioral Neuroscience Research Branch
  • Integrative Neuroscience Research Branch
  • Translational Addiction Medicine Branch
  • Core Facilities
  • Women Scientist Advisors
  • Careers at NIDA IRP
  • Technology Development Initiative
  • Diversity and Outreach Training Programs
Home / Organization / Translational Addiction Medicine Branch
  • National Institute on Drug Abuse
  • NIH Intramural Research Program
  • National Institutes of Health
  • Health and Human Services
  • USA.GOV
  • Treatment Information
  • Contact Us
  • Careers at NIDA IRP
  • Accessibility
  • Privacy
  • HHS Vulnerability Disclosure
  • Freedom of Information Act
  • Document Viewing Tools
  • Offsite Links
  • National Institute on Drug Abuse
  • NIH Intramural Research Program
  • National Institutes of Health
  • Health and Human Services
  • USA.GOV
  • Treatment Information
  • Contact Us
  • Careers at NIDA IRP
  • Accessibility
  • Privacy
  • HHS Vulnerability Disclosure
  • Freedom of Information Act
  • Document Viewing Tools
  • Offsite Links